Welireg 40MG tabs
Ended Awarded Last action
- Contract number
- 36C26025F0139
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $44,103
Award facts
- Contract value 100% obligated
- $44,102.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $22,051 | |
| Other Administrative Action | -$154,360 | |
| Original award | $176,411 |
About this award
Merck Sharp & Dohme LLC was awarded a delivery order valued at $44.1M for WELIREG (belzutifan) 40 mg tablets by the Department of Veterans Affairs, specifically Veterans Integrated Service Network 20. This firm fixed-price delivery order, issued on February 10, 2025, with an ultimate completion date of September 30, 2025, represents procurement of an oncology therapeutic used in the treatment of renal cell carcinoma. The award is issued under Merck's parent Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with the Department of Veterans Affairs, valued at $5.84 billion and extending through May 31, 2030. No set-aside designation was applied to this procurement. The place of performance is located in Carrollton, Texas.
This delivery order is one of numerous WELIREG procurements across the Veterans Health Administration, reflecting the Department of Veterans Affairs' commitment to providing specialty oncology therapeutics to eligible beneficiaries. The award note indicates unpaid invoices relating to two additional bottles to be paid, suggesting this delivery order addresses existing supply obligations within the VA's cancer treatment programs. Merck's extensive federal contracting history with the VA and other agencies demonstrates its established role as a critical supplier of specialty pharmaceuticals and vaccines to the federal healthcare system.
Quick answers
Who was awarded contract 36C26025F0139?
36C26025F0139 was awarded to Merck Sharp & Dohme LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on February 10, 2025.
How much is contract 36C26025F0139 worth?
The government has obligated $44,103 on 36C26025F0139.
Is contract 36C26025F0139 an order under another contract?
Yes. 36C26025F0139 is a delivery order under 36F79718D0509, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0139 competed?
The extent of competition for 36C26025F0139 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award